Plain-English translation of NCT06679062 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is testing a medication called to see if it can help people who are struggling with both post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD). The study focuses on how the medication affects sleep, because poor sleep often makes both conditions worse. Half of the participants will receive the medication and half will receive a placebo (inactive pill), so researchers can see if the medication really works.
Many people who experience trauma also struggle with drinking, and both conditions make sleep much worse. This medication might help break that cycle by improving sleep, which could reduce cravings to drink and ease trauma-related symptoms. The study will help doctors understand whether this treatment could help people recover from both conditions at the same time.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would first complete a one-week screening period, then randomly receive either the medication or a placebo for 13 days. During this time, you would attend lab visits to test your reactions to alcohol cues, complete daily check-ins about your sleep and drinking using your phone, and return to the clinic on day 14 for a final assessment. The whole study lasts about 3 weeks, and researchers will track your sleep quality, drinking, alcohol cravings, and trauma symptoms throughout.
AI-generated summary from trial data ยท Jul 2, 2026 ยท Not medical advice
United States